Clinical Trial Update: TRACE: Tirapazamine-Radiation And Cisplatin Evaluation [Phase 3]

View source ↗

Summary

A Phase 3 trial (TRACE) evaluating tirapazamine with radiation and cisplatin for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Tirapazamine (tirapazamine)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED